title: [Percutaneous recanalization of occluded renal arteries].
abstract: Acute embolic renal artery occlusion is usually clinically typical. In case of early diagnosis, an in situ thrombolysis may be effective. As thrombosis often progressively completes a severe renal artery stenosis, the classical clinical description of renal infarction (lumbar pain, hematuria) is frequently not present. The kidney parenchyma downstream from the renal arterial occlusion is not always irreparably lost: collateral circulation may preserve nephron viability, which requires a lower perfusion pressure than glomerular filtration. An iodine, isotopic, or MR gadolinium nephrogram may prove this viability. Over the last 10 years, we attempted 21 percutaneous recanalizations of renal artery occlusion. Mean patient age was 62 years (44-85). All were hypertensive. Serum creatinin level of 17 patients was above 130 micromoles/ml. Three patients were previously hemodialysed. We observed 8 failures, without any complication. Thirteen immediate technical successes occurred, but one rethrombosis occurred at Day 1. Immediate complications were seen in 2 patients: 1 acute pulmonary edema, 1 puncture site false aneurysm. The mean follow up of the 12 technical successes was 26 months (18-60). One rethrombosis occurred at 6 months. Hypertension was unchanged in 4 patients and improved in 8. In all patients with renal insufficiency, a significative improvement of serum creatinine level was observed. It was possible to discontinue hemodialysis in the 3 patients previously hemodialysed. One predictive factor of success was recognized: a short delay (shorter than 90 days) between occlusion and recanalization. Percutaneous recanalization must be proposed in case of renal artery occlusion, especially to avoid vascular azotemia and dialysis, even if the kidney fed by the occluded artery is small.
authors.affiliation: Service de Radiologie, CHU G. Montpied, BP 69, 63003 Clermont-Ferrand Cedex. lboyer@chu-clermontferrand.fr
authors.forename: L
authors.initials: L
authors.lastname: Boyer
authors.forename: A
authors.initials: A
authors.lastname: Ravel
authors.lastname: De Fraissinette B
authors.forename: T
authors.initials: T
authors.lastname: Chahid
authors.forename: J M
authors.initials: JM
authors.lastname: Garcier
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D003097:Collateral Circulation; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006978:Hypertension, Renovascular / Q000209:etiology / Q000601:surgery; D007238:Infarction / Q000209:etiology; D007668:Kidney / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011654:Pulmonary Edema / Q000209:etiology; D012008:Recurrence; D012078:Renal Artery Obstruction / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D006435:Renal Dialysis; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D003404:Creatinine